Stockscreener 앱 받기
3.07
0.33%
0.010
전일 마감가:
$3.06
열려 있는:
$3.08
하루 거래량:
73,032
Relative Volume:
0.30
시가총액:
$83.11M
수익:
-
순이익/손실:
$-49.81M
주가수익비율:
-1.4239
EPS:
-2.156
순현금흐름:
$-42.93M
1주 성능:
+0.66%
1개월 성능:
+22.80%
6개월 성능:
-15.89%
1년 성능:
-66.26%
1일 변동 폭
$3.05
$3.08
1주일 범위
$3.00
$3.10
52주 변동 폭
$1.60
$15.04
Alto Neuroscience Inc Stock (ANRO) Company Profile
명칭
Alto Neuroscience Inc
전화
773-255-5012
주소
650 CASTRO STREET, SUITE 450, MOUNTAIN VIEW
ANRO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ANRO
Alto Neuroscience Inc
|
3.07 | 83.92M | 0 | -49.81M | -42.93M | -2.156 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Alto Neuroscience Inc Stock (ANRO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-10-23 | 다운그레이드 | Rodman & Renshaw | Buy → Neutral |
| 2024-10-23 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2024-09-03 | 개시 | Wedbush | Outperform |
| 2024-02-27 | 개시 | Jefferies | Buy |
| 2024-02-27 | 개시 | Robert W. Baird | Outperform |
| 2024-02-27 | 개시 | Stifel | Buy |
| 2024-02-27 | 개시 | TD Cowen | Outperform |
| 2024-02-27 | 개시 | William Blair | Outperform |
모두보기
Alto Neuroscience Inc 주식(ANRO)의 최신 뉴스
Using data models to predict Alto Neuroscience Inc. stock movementPortfolio Positioning Strategy With Timing - Newser
Real time pattern detection on Alto Neuroscience Inc. stockFree Trend Following Strategy With Stop Loss - Newser
Comparing Alto Neuroscience Inc. in custom built stock radarsLong-Term Growth Trend Summary With Confidence - Newser
Alto Neuroscience (ANRO) Projected to Post Quarterly Earnings on Tuesday - Defense World
Sector ETF performance correlation with Alto Neuroscience Inc.Short Term Profit Strategy with Entry Cues - Newser
Using AI based signals to follow Alto Neuroscience Inc.Free Low Risk Swing Trade Opportunity List - Newser
Financial Contrast: Swedish Orphan Biovitrum (OTCMKTS:BIOVF) and Alto Neuroscience (NYSE:ANRO) - Defense World
Real time alert setup for Alto Neuroscience Inc. performanceStock Entry Points Based on Technicals - Newser
September 19, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against ANRO - GlobeNewswire Inc.
Class Action Lawsuit Alert: Levi & Korsinsky Reminds Alto Neuroscience, Inc. (ANRO) Investors of September 19, 2025 Deadline - ACCESS Newswire
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Alto Neuroscience - MarketScreener
Alto Neuroscience and the Legal Quagmire: Assessing Risks and Investor Rights in a Post-IPO Meltdown - AInvest
Alto Neuroscience, Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before September 19, 2025 to Discuss Your RightsANRO - PR Newswire
Analyzing drawdowns of Alto Neuroscience Inc. with statistical toolsShort-Term Profit Alert With Entry Forecast - Newser
Forecasting Alto Neuroscience Inc. price range with options dataFree Low Risk Picks for Daily Trading - Newser
ROSEN, A LONGSTANDING FIRM, Encourages Alto Neuroscience, - GlobeNewswire
Class Action Alert: Levi & Korsinsky Reminds Alto Neuroscience, Inc. (ANRO) Investors of September 19, 2025 Deadline - ACCESS Newswire
Shareholders that lost money on Alto Neuroscience, Inc.(ANRO) should contact The Gross Law Firm about pending Class ActionANRO - Morningstar
Levi & Korsinsky Urges Alto Neuroscience, Inc. (ANRO) Shareholders to Act Before Lead Plaintiff Deadline September 19, 2025 - ACCESS Newswire
Pomerantz Law Firm Announces the Filing of a Class Action Against Alto Neuroscience, Inc. and Certain OfficersANRO - PR Newswire
Levi & Korsinsky Reminds Alto Neuroscience, Inc. Investors - GlobeNewswire
ANRO Investors Have Opportunity to Lead Alto Neuroscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm - cnhinews.com
Why Alto Neuroscience Inc. is moving todayReliable Setup Screener with Low Risk - Newser
Bragar Eagel & Squire, P.C. Reminds Investors of Class - GlobeNewswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Alto Neuroscience - Morningstar
Alto Neuroscience Inc. Crosses 200 Day MA — Signal or NoiseCapital Protection Trading Strategies Gain Interest - beatles.ru
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 19, 2025 in Alto Neuroscience, Inc. LawsuitANRO - MarketScreener
Shareholders that lost money on Alto Neuroscience, Inc.(ANRO) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - PR Newswire
Allianz Asset Management GmbH Trims Stock Holdings in Alto Neuroscience, Inc. (NYSE:ANRO) - Defense World
Why Alto Neuroscience Inc. stock attracts strong analyst attentionMonthly Trade Result and Signal Summary - Newser
Quant Tools Rank Alto Neuroscience Inc. as High Risk High RewardInvestment Playbook for Growing Markets Shared - beatles.ru
ANRO Investors Have Opportunity to Lead Alto Neuroscience, Inc. Securities Fraud Lawsuit - PR Newswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Alto Neuroscience, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Alto Neuroscience, Inc. Investigated for Breaches of Fiduciary DutyContact the DJS Law Group to Discuss Your Rights – ANRO - The Globe and Mail
ANRO SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Alto Neuroscience, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Investors Urged to Contact Levi & Korsinsky for Information Before September 19, 2025Alto Neuroscience, Inc. (ANRO) - TradingView
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 19, 2025 in Alto Neuroscience, Inc. LawsuitANRO - PR Newswire
ALTO NEUROSCIENCE, INC. (NYSE: ANRO) SHAREHOLDER ALERT - GlobeNewswire
Tools to assess Alto Neuroscience Inc.’s risk profileFree Capital Protection Trading Strategies - Newser
Published on: 2025-08-04 06:43:16 - Jammu Links News
Why is Alto Neuroscience Inc. stock attracting strong analyst attentionAchieve rapid portfolio appreciation today - Jammu Links News
ANRO INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Alto Neuroscience, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
What analysts say about Alto Neuroscience Inc. stockStay informed with daily expert analysis - Jammu Links News
Alto Neuroscience Inc. Stock Analysis and ForecastBuild wealth with professional market analysis - Jammu Links News
ANRO Investors Have the Opportunity to Lead the Alto Neuroscience Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - PR Newswire
What is the risk reward ratio of investing in Alto Neuroscience Inc. stockUnlock daily market insights for better trades - Jammu Links News
What institutional investors are buying Alto Neuroscience Inc. stockUnstoppable investment returns - Jammu Links News
What are analysts’ price targets for Alto Neuroscience Inc. in the next 12 monthsInvest smarter with real-time trading signals - Jammu Links News
Bragar Eagel & Squire, P.C. Is Reminds Investors of Class - GlobeNewswire
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Alto Neuroscience - GlobeNewswire
Pomerantz Law Firm Announces the Filing of a Class Action Against Alto Neuroscience, Inc.and Certain Officers – ANRO - FinancialContent
Alto Neuroscience Inc (ANRO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):